PeopleSpheres
Venture Round in 2023
PeopleSpheres is a Paris-based company that specializes in providing human resources management software solutions. Founded in 2010 and formerly known as NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. Recognizing a gap in the market for tailored HR management solutions, PeopleSpheres developed a customizable and scalable platform designed to meet the diverse needs of businesses. The company collaborates with leading national HR service providers to better serve American enterprises, ensuring that its offerings are both suitable and sustainable for a wide range of clients. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.
Opensee is a Paris-based fintech company focused on providing self-service analytics solutions for financial institutions. Founded by experts from the financial and technology sectors, Opensee addresses the challenges of managing vast amounts of data by enabling business users to directly access and analyze their information on demand. This capability allows institutions to conduct in-depth analysis and what-if scenarios on billions of data points, improving efficiency and responsiveness to regulatory and business needs. The platform empowers financial organizations to manage risk in capital markets, streamline resources in commercial and retail banking, and enhance market intelligence through better utilization of transaction data. By transforming big data challenges into competitive advantages, Opensee aims to support financial institutions in making informed decisions swiftly and effectively.
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.
Qubit Pharmaceuticals
Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based company founded in 2020 that specializes in drug discovery technology. Established through collaboration among notable institutions such as CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, it draws on over 20 years of research and development recognized by prestigious awards. The company has developed a drug discovery simulation platform that aims to reduce both the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform conducts virtual screening and visualization to identify promising drug candidates. This innovative approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
PeopleSpheres
Venture Round in 2021
PeopleSpheres is a Paris-based company that specializes in providing human resources management software solutions. Founded in 2010 and formerly known as NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. Recognizing a gap in the market for tailored HR management solutions, PeopleSpheres developed a customizable and scalable platform designed to meet the diverse needs of businesses. The company collaborates with leading national HR service providers to better serve American enterprises, ensuring that its offerings are both suitable and sustainable for a wide range of clients. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Teach on Mars
Venture Round in 2019
Teach on Mars SAS is a prominent provider of mobile-led learning technology based in France, with offices in Sophia Antipolis, Paris, Milan, and London. Founded in 2013, the company has established itself as a leader in the mobile learning sector, delivering innovative solutions to over 100 clients across more than 60 countries. Their platform enables trainers to design mobile courses and learning games, manage training progress, and analyze learning metrics through a user-friendly interface accessible on smartphones and tablets. Additionally, Teach on Mars offers various services, including mobile learning training, certification, app marketing, and integration with professional content marketplaces. The company's commitment to social responsibility is reflected in its investment of 1% of revenues into education projects that align with the UN Sustainable Development Goals.
Tiller Systems
Series B in 2018
Tiller Systems SAS is a Paris-based company that specializes in developing cloud-based point of sale (POS) software solutions for restaurants and merchants. Founded in March 2014, Tiller's management tools enable users to accept various payment types, integrate partner applications, and effectively oversee staff and inventory in real time. The software features a mobile POS system that allows for the management of both in-store and online orders from a single platform. Additionally, Tiller offers a web dashboard that facilitates catalog updates, sales tracking, employee payments, stock alerts, customer relationship management, and access to real-time reporting and performance metrics. With additional offices in Barcelona and Milan, Tiller Systems aims to empower businesses to make informed decisions and enhance their operational efficiency.
Nanomakers
Venture Round in 2018
Nanomakers is a Paris-based company founded in 2010 that specializes in the design, manufacture, and marketing of silicon-based nanopowders. These patented, nano-scale powders are utilized to enhance the mechanical reinforcement of materials such as metal alloys and elastomers, as well as to improve the energy storage density of lithium-ion batteries through silicon-carbon composites in anodes. The company's nanopowders, including silicon carbide and silicon, significantly enhance the mechanical, thermal, and chemical performance of various industrial materials. Nanomakers serves multiple sectors, including semiconductors, energy storage, aeronautics, space, and automotive industries, by providing innovative solutions that contribute to advancements in technology and material performance.
Enterome
Debt Financing in 2018
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Pixium Vision
Series A in 2013
Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative retinal implant systems to restore vision for individuals who have lost sight due to degeneration of photoreceptor cells in the retina. Established in 2011, Pixium Vision's primary product is the PRIMA System, a bionic vision system designed to improve visual perception and promote greater independence among users. The company is advancing several devices, including the IRIS1, currently undergoing clinical trials, and the next-generation IRIS2, which aims to enhance visual acuity. Additionally, Pixium is working on the IRIS3, a sub-retinal implant that promises further improvements in vision. The company collaborates with prestigious institutions such as Stanford University, Moorfields Eye Hospital, and the Institut de la Vision, utilizing cutting-edge research in neural processing and micro-electronics to drive its innovations. Pixium Vision is supported by a consortium of prominent European venture capital firms.
Greenbureau
Seed Round in 2012
Greenbureau SA, founded in 2011 and based in Paris, France, operates an online platform that centralizes personal finance services, including digital billing and account management. The platform connects users to major suppliers and public services in France, allowing for the automatic retrieval of invoices and monthly statements through a single login. It also offers budgeting tools and alert options, with unlimited storage for financial documents. To enhance customer interactions, Greenbureau provides solutions such as Zen Call, which manages customer waiting times, Zen Care, a digital alternative to abandoned calls, and Call Bot, which qualifies customer requests for efficient agent response. The company generates revenue through partnerships with major providers, enabling it to offer its services free of charge to users.
Ividence, Inc. is an email advertising platform based in Paris, France, with additional offices in New York and San Francisco. Founded in 2008, the company specializes in connecting advertisers with publishers through its email advertising exchange platform. Ividence utilizes behavioral targeting technology to effectively match offers with appropriate audiences, enhancing the relevance of ads in newsletters and transactional emails. The platform allows publishers to monetize their email lists while maintaining control over their content. Additionally, Ividence manages various aspects of email campaigns, including list hygiene, bid management, feedback handling, and real-time reporting, facilitating campaign optimization for lead generation and customer conversion.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
Aldebaran Robotics
Series C in 2011
Aldebaran Robotics, founded in 2005 and based in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots primarily for entertainment and assistance purposes. The company's notable products include NAO, a 58-cm tall humanoid robot designed to be a friendly companion capable of movement, recognition, auditory engagement, and conversation. Another key product, Pepper, is a social robot that interacts with humans, recognizes their emotions, and operates autonomously. Additionally, Romeo, a larger humanoid robot at 140 cm, is developed for research focused on assisting the elderly and individuals with reduced autonomy, featuring functionalities such as opening doors, climbing stairs, and grasping objects. Aldebaran Robotics aims to advance the field of humanoid robotics through innovative solutions that enhance human-robot interaction and support various applications in care and therapy.
ConfortVisuel
Venture Round in 2010
ConfortVisuel is an online retailer specializing in optical products, catering to a diverse clientele with a broad range of offerings. With five years of experience and a customer base of 12,000, the company has established itself as a significant player in the market. Its website is designed for smooth navigation, emphasizing user experience. ConfortVisuel provides economical optical products that are tested and adaptable to individual sight requirements. Additionally, the company offers a rental service, allowing visually impaired customers to test and adapt visual aids before making a purchase. Unique to ConfortVisuel is its ability to facilitate third-party online payments and the presence of a showroom in Paris, enhancing customer convenience and engagement.
Aquafadas
Series A in 2009
Aquafadas specializes in digital publishing technology that facilitates the creation and distribution of interactive digital content, including magazines, newspapers, corporate documents, books, and comics, across various platforms such as smartphones, tablets, and the web. The company provides tailored content creation and distribution solutions, helping businesses enhance their digital publishing strategies while reducing costs. Its client roster includes notable names like Lagardère, Mondadori, and Vodafone. Aquafadas is also recognized for its role in advancing digital publishing standards through memberships in organizations like the International Digital Publishing Forum and IdeAlliance. As part of the Rakuten group, it also contributes its expertise to Kobo, a leading e-reader provider. With offices in Montpellier, Paris, and New York, Aquafadas continues to develop innovative tools and applications for mobile-first audiences, focusing on improving engagement and efficiency for its clients.
Sparus Software
Series B in 2007
Sparus Software is a Paris-based independent software vendor specializing in mobile device management solutions. The company develops and markets the EveryWAN Mobility Manager, a comprehensive software suite that facilitates the deployment and management of mobile handheld devices across various wireless networks, including GPRS, Edge, 3G, and WiFi. By providing these capabilities, Sparus Software aims to help enterprises manage their mobile devices more efficiently and cost-effectively, ultimately leading to reduced operating expenses.
Augure is a software company founded in 2002 in Paris, specializing in influencer marketing and public relations solutions. The company offers a platform that assists brands and agencies in managing their communication strategies by bridging the gap between traditional PR and influencer marketing. With over 1,000 clients utilizing the platform daily, Augure enables communication, PR, and public affairs teams to engage with relevant influencers, streamline campaign management, and enhance their media presence on social networks. In addition to its software, Augure provides consulting services through its data services team, helping clients interpret and leverage data to optimize their influencer marketing strategies. The company operates primarily in Europe and Latin America, serving a diverse range of clients, including prominent organizations in the corporate sector.
Groupe Frères Blanc
Acquisition in 2006
Groupe Frères Blanc is a prominent player in the French gastronomy sector, operating a network of 15 esteemed restaurants and brasseries in Paris, Provence, and internationally. Established in the 1950s by brothers Pierre and Jacques Blanc, the group has built a reputation for exceptional dining experiences, showcasing quality cuisine and the French art de vivre. In addition to its restaurant operations, the company also offers online reservation services for both individual and group bookings, enhancing customer convenience. Based in Paris, Groupe Frères Blanc continues to be a significant influence in the culinary landscape of France.
Leyton
Private Equity Round in 2006
Leyton is a consulting firm founded in 1997 and headquartered in Paris, France, specializing in cost optimization and innovation funding. With over 20 years of experience, Leyton has become one of the largest specialists in helping clients enhance their global performance. The firm focuses on areas such as tax credit research, start-up consulting, purchase optimization, insurance audits, and management of receipts. Leyton's expertise in the optimization of Federal and State Research and Development (R&D) Tax Credits is particularly notable in the United States, where it employs a team of over 850 professionals. The firm serves various industries, including software, engineering, manufacturing, and food and beverage, ensuring that its consultants possess relevant industry experience to effectively address clients' challenges.
OpenTrust
Series C in 2005
OpenTrust designs and develops solutions to address complex security challenges faced by enterprises. The company focuses on creating trusted IT infrastructures that secure information across various levels within organizations, supporting shared computing models like cloud computing. OpenTrust's platform integrates seamlessly with technologies from leading vendors and offers a range of products, including certificate-based strong authentication, smart card management, secure document exchange, digital signatures, and proof management. These products are available as licensed software or private cloud services. OpenTrust also provides professional services for product integration and offers a comprehensive training and certification program. Its solutions have been implemented by numerous multinational enterprises and are utilized by over 2 billion users across 100 countries. Founded in 2000 as IdealX S.A. and rebranded as OpenTrust S.A. in 2007, the company is headquartered in Paris, France.
Interactif Visuel Système
Venture Round in 2000
Interactif Visuel Système is a Paris-based company founded in 1996 that specializes in developing and marketing computer software. The company focuses on designing sales aid systems tailored for the optic, ophthalmologic, and cosmetic sectors. Its offerings serve as technological support tools for opticians, enhancing their sales processes and customer interactions.